You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Canada

Feb 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Retail sales of consumer health products see good growth in 2011

An ageing population along with an increased emphasis on preventative healthcare continued to drive retail sales of consumer health products in 2011. At the same time, the slow pace of economic recovery and on-going uncertainty resulted in still low consumer confidence. The search for savings where possible resulted in the overall positive performance of private label and generic products in many categories of consumer health. This tendency was encouraged by retailers putting an emphasis on revenue through the development of store brands.

Canada’s ageing population continues to drive sales

The Canadian population aged 65 and over grew by more than 10% over the review period. As the proportion of seniors in Canada increases, so does the number of age-related ailments, leading to demand for products that help to alleviate these conditions. Product development and OTC switches further aided sales, examples being Aleve and Voltaren Emulgel in analgesics. These obtained OTC status over the review period and continued to see solid demand supported by older Canadians in 2011.

McNeil Consumer Healthcare maintains number one position

While domestic manufacturers do have a presence on the Canadian OTC market, particularly in generic pharmaceuticals and vitamins and dietary supplements, overall the Canadian market is led by multinationals. With strong brands such as Tylenol and Nicorette, McNeil Consumer Healthcare (a division of Johnson & Johnson), remained number one in terms of value share, followed by Wyeth. This was despite a troublesome year in terms of product recalls and resulting negative media attention. However, due to leadership in vitamins and dietary supplements, domestic player Jamieson Laboratories Ltd ranked third overall.

Drugstores remain retail channel of choice

Drugstores remained a shopping destination for consumer health products in Canada at the end of the review period. The leading retail chains such as Shoppers Drug Mart, Jean Coutu, Katz Group and others continued to attract customers with knowledgeable staff and a wide selection of products across multiple price ranges. Furthermore, many drugstores continued to expand their offerings to include a larger selection of non-health-related products to encourage convenience shopping and boost shopping basket sizes.

Healthy sales growth projected to continue through forecast period

Retail sales of consumer health products are projected to grow steadily over the period to 2016. Sales will be bolstered by an ageing population as well as a strong emphasis on preventative health and self-care. The largest growth categories will likely come from products that address age-related ailments, such as analgesics and digestive aids. Vitamins and dietary supplements, however, will continue to face a difficult operating environment as Health Canada is set to reinforce the existing mandatory pre-marketing approval regulations.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Canada with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Canada, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Canada for free:

The Consumer Health in Canada market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Canada?
  • What are the major brands in Canada?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Canada - Industry Overview

EXECUTIVE SUMMARY

Retail sales of consumer health products see good growth in 2011

Canada’s ageing population continues to drive sales

McNeil Consumer Healthcare maintains number one position

Drugstores remain retail channel of choice

Healthy sales growth projected to continue through forecast period

KEY TRENDS AND DEVELOPMENTS

Canada’s slow economic recovery helps private label products

Older Canadians seek consumer health products to smooth ageing process

Canadians take a greater share of responsibility for their health

Natural Health Product regulations impact potential of some products

Competition between OTC and Natural Health Products continues to grow

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011

MARKET DATA

  • Table 2 Sales of Consumer Health by Category: Value 2006-2011
  • Table 3 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 4 Consumer Health Company Shares 2007-2011
  • Table 5 Consumer Health Brand Shares 2008-2011
  • Table 6 Penetration of Private Label by Category 2006-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

SWITCHES

DEFINITIONS

Analgesics

Cough, cold and allergy (hay fever) remedies

Digestive remedies

Medicated skin care

NRT smoking cessation aids

Eye care

Ear care

Adult mouth care

Calming and sleeping products

Wound treatments

Emergency contraception

Vitamins and dietary supplements

Tonics and bottled nutritive drinks

Weight management products

Sports nutrition products

Herbal/traditional products

SOURCES

  • Summary 1 Research Sources

Consumer Health in Canada - Company Profiles

Church & Dwight Co Inc in Consumer Health (Canada)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Church & Dwight Canada Corp: Competitive Position 2011

Jamieson Laboratories Ltd in Consumer Health (Canada)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Jamieson Laboratories Ltd: Competitive Position 2011

Prestige Brands International Inc in Consumer Health (Canada)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Prestige Brands International Inc: Competitive Position 2011

Swiss Herbal Remedies Ltd in Consumer Health (Canada)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Swiss Herbal Remedies Ltd: Competitive Position 2011

Teva Canada Ltd in Consumer Health (Canada)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Canada - Category Analysis

HEADLINES

TRENDS

  • It is estimated that 20% of Canadians have a canker sore at some time. The cause of these sores is not fully understood but they occur most often in people aged between 10 and 40, and more so among women. Retail sales of adult mouth care products, with many formulated for canker sore treatments, grew by 2% during 2011 to reach a value of close to C$4 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • Church & Dwight Ltd’s Orajel accounted for a 23% value share in 2011. The Orajel brand is offered in two varieties, for mouth sores (canker sores) and toothache. The on-going marketing campaigns for Orajel focuses on “instant relief” from pain and keeping the brand at the top of consumer awareness.

PROSPECTS

  • Growth over the forecast period will be driven in large part by population growth. With the causes of canker sores still not fully understood the number of cases, and therefore sales of relief products, moves in correlation to the population.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Canada - Category Analysis

HEADLINES

TRENDS

  • Canada’s ageing population combined with strong growth from new product lines represented the driving forces of analgesics in 2011. The number of Canadians over the age of 65 increased by almost 3% over the review period, to 4.9 million by the end of 2011. With seniors being the highest spending group on healthcare, it is no wonder that the analgesics category continues to grow.

SWITCHES

COMPETITIVE LANDSCAPE

  • Wyeth Consumer Healthcare Inc was once again the largest marketer within the Canadian analgesics environment, holding a 29% value share in 2011. Advil and Robaxacet continue to be Wyeth’s best-selling brands in Canada. Advil, an anti-inflammatory analgesic, is used primarily for menstrual cramps, headaches, arthritis, and acute injuries such as sprains and strains. Wyeth’s second-best selling brand Robaxacet is a combination of acetaminophen and methocarbamol, which are together very effective at alleviating pain from muscle-related spasms and cramps. Both Advil and Robaxacet are heavily promoted through multi-channel advertising campaigns spanning TV commercials, magazines and websites.

PROSPECTS

  • Statistics Canada has estimated that by 2036 one-quarter of Canadians will be considered a senior, aged 65 or older. In a recent report by the Canadian Pain Society it was estimated that the proportion of seniors experiencing high levels of pain can be as high as 65% for those living in the community and up to 80% for those living in long-term care facilities. The ageing population and related ailments, such as pains and aches first and foremost, will continue to drive demand for analgesics in Canada. This demand will also continue to shape up new products and their marketing with principal focus on the rapidly growing older demographic.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Canada - Category Analysis

HEADLINES

TRENDS

  • A study released by Université Laval in 2011 revealed that 40% of Canadians are affected by sleep disorders. Furthermore, the survey indicated that many Canadians prefer to treat their symptoms without a doctor’s help. Thus, while 13% of respondents consulted a physician and 10% used prescription products, 9% of Canadians indicated the use of natural products, 7% use over-the-counter medications, while 5% use alcohol as a treatment for their sleep problems.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Consumer Healthcare Canada Inc continued to lead sales of calming and sleeping products in 2011, with a 42% value share. GlaxoSmithKline’s leading brand, Nytol, held a 38% value share among brands. Nytol is well-displayed and well-positioned in stores and is well known to consumers, which helps the brand maintain its leadership.

PROSPECTS

  • As Canadians continue to increase the amount of time they spend using screens and technology they are likely to continue to experience disruptions in natural sleep quality. This increased reliance on technology combined with higher stress levels from economic uncertainty will drive demand for calming and sleeping aids through the forecast period – a preferred method of treating sleep problems.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Canada - Category Analysis

HEADLINES

TRENDS

  • Environmental changes are increasing the length of the allergy season in Canada. Over nine million Canadians are said to suffer from allergies and are facing longer periods of discomfort. Studies have shown increases as drastic as a rise of 27 days over a 10-year period, 1995-2005, in cities such as Saskatoon. The rate of pollen production has also shown a dramatic increases, worsening allergic reactions for those are affected by this common irritant. Additionally, the length and intensity of seasonal flu in 2010/2011 also contributed to demand for products that can help alleviate flu and cold symptoms. Overall, cough, cold, and allergy remedies increased by 4% in current value terms to C$755 million in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Consumer Healthcare accounted for the largest value share, with 21% of sales in 2011. This large share is the aggregate of strong value shares of McNeil products through antihistamines/allergy remedies, paediatric cough, cold, and allergy remedies, combination products, cough remedies and oral decongestants. McNeil’s most notable brands include Reactine, Benadryl, Tylenol, Benylin, Sudafed and Sinutab.

PROSPECTS

  • Over the forecast period sales of cough, cold, and allergy remedies sales are projected to see a constant value CAGR of 2% to reach C$834 million in 2016. This growth will in large part be through the increase of the antihistamines/allergy remedies category, as the length and intensity of allergy seasons is expected to remain on the rise.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Canada - Category Analysis

HEADLINES

TRENDS

  • Canada’s ageing population continues to be the main driving force behind growth of digestive remedies. Statistics Canada forecast a large shift in Canada’s demographics in the short- to mid-term. Over 2001 to 2026 the percentage of Canada’s population in the senior segment – over the age of 65 – is expected to increase from 13% to 20%. With seniors spending more per capita on healthcare, including digestive remedies, this changing demographic is the largest single factor affecting digestive remedies’ growth in Canada. In 2011 retail sales of digestive remedies grew 3% in current value to reach C$372 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Consumer Healthcare – a division of Johnson & Johnson – remained the number one company in digestive remedies with a value share of 24% in 2011. Making up the majority of McNeil’s sales in the category is the top-selling diarrhoeal remedy Imodium, as well as Rolaids and Zantac, both with strong footings in their respective categories. Furthermore, Zantac has become the top recommended indigestion/heartburn remedy in Canada, according to a 2011 OTC recommendation surveys of pharmacists and physicians published by Drugstore Canada magazine.

PROSPECTS

  • Over the forecast period digestive remedies’ sales are projected to see a constant value CAGR of 2% to reach C$412 million in 2016.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 42 Digestive Remedies Company Shares by Value 2007-2011
  • Table 43 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Canada - Category Analysis

HEADLINES

TRENDS

  • Consumers continue to turn to healthcare professionals for ear care related issues. As a result the resulting stagnant growth figures seen in recent years continued in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Shoppers Drug Mart Inc remains number one in value terms, accounting for a 17% value share in 2011. The Life private label brand offers a cheaper alternative to other treatment options.

PROSPECTS

  • Over the forecast period sales of ear care products are projected to decline marginally in constant value terms to stand at less than C$8 million in 2016. This declining sales figure over the forecast period is expected due to a lack of product innovation and an increasing reliance on doctors for the treatment of ear care issues.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2006-2011
  • Table 47 Sales of Ear Care: % Value Growth 2006-2011
  • Table 48 Ear Care Company Shares by Value 2007-2011
  • Table 49 Ear Care Brand Shares by Value 2008-2011
  • Table 50 Forecast Sales of Ear Care: Value 2011-2016
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Canada - Category Analysis

HEADLINES

TRENDS

  • Increased availability and knowledge of emergency contraception products has bolstered recent growth in Canada. Women’s organisations and public health centres have been working to educate women, primarily younger women, of the contraception methods available. This increased awareness has led directly to increased retail sales of emergency contraception products in the country.

COMPETITIVE LANDSCAPE

  • Plan B is the only brand available in emergency contraception in Canada, sold by Duramed Pharmaceuticals Inc. However, the brand has faced competition from generic version introduced to the Canadian market, and which retail at lower prices compared with Plan B.

PROSPECTS

  • Retail sales of emergency contraception products are projected to see a constant value CAGR of 9% over the forecast period to reach C$38 million in 2016. This growth will be as a result of increased awareness of the contraception options available.

CATEGORY DATA

  • Table 52 Sales of Emergency Contraception: Value 2006-2011
  • Table 53 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 54 Emergency Contraception Company Shares by Value 2007-2011
  • Table 55 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 56 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 57 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Canada - Category Analysis

HEADLINES

TRENDS

  • Canada’s ageing population continues to be the main driving force behind demand for eye care products in the country. Statistics Canada demographic studies show a shift in Canada’s demographics. Over 2001-2026 the percentage of Canada’s population accounted for by senior consumers – ie those over the age of 65 – is expected to increase from 13% to 20%.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Consumer Healthcare remained the number one provider of OTC eye care products in Canada at the end of the review period with a 28% value share in 2011. The company markets well-established and well-known brands Visine Allergy, with a 24% value share in allergy eye care, and Visine, with a 32% value share in standard eye care.

PROSPECTS

  • The percentage of Canadians aged 65 plus is projected to increase from 14% to 16% over the forecast period. As eye-related problems increase with age, changing demographics will be among the key factors supporting sales of eye care products over the forecast period. Increased use of technology (often leading to dry and tired eyes) will also be a factor boosting demand.

CATEGORY DATA

  • Table 58 Sales of Eye Care by Category: Value 2006-2011
  • Table 59 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 60 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 61 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 62 Eye Care Company Shares by Value 2007-2011
  • Table 63 Eye Care Brand Shares by Value 2008-2011
  • Table 64 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Canada - Category Analysis

HEADLINES

TRENDS

  • Scepticism among many Canadians regarding the effectiveness and safety of herbal/traditional products, the restrictive regulatory environment and competition from standard OTC products once again hurt sales in 2011, with slight negative growth to C$531 million.

COMPETITIVE LANDSCAPE

  • With a strong presence in medicated confectionery with its Halls brand, Cadbury Adams Canada Inc ranked first in 2011, accounting for a 13% value share. Halls is a well-established brand providing temporary relief from coughs (easily carried for use on the go) and is supported by advertising to maintain a high level of consumer awareness. Halls’ range also includes a wide variety of flavours, including further enhanced products with ingredients such as vitamin C and Echinacea. Halls’ principal rivals include Ricola and Fisherman’s Friend, with Ricola receiving strong support in media advertising.

PROSPECTS

  • The growth of most herbal/traditional products is expected to be slow over the forecast period due to the number of factors affecting demand and sales. These include the regulatory environment, consumer scepticism of the effectiveness of some products, and competition from standard OTC products in some categories, where the latter are seen as more efficient in addressing and alleviating symptoms. Over the forecast period retail sales of herbal/traditional products are projected to see a slightly negative constant value CAGR to stand at C$520 million in 2016.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 68 Herbal/Traditional Products Company Shares 2007-2011
  • Table 69 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Canada - Category Analysis

HEADLINES

TRENDS

  • A strained Canadian medical system is encouraging Canadians to take their health problems into their own hands. Studies published annually by Drugstores Canada magazine and other industry publications indicate that in 2010 the percentages of Canadians aged 20-34 and 35-44 who reported being without a family doctor stood at 27% and 18% respectively. Without a family doctor these individuals are turning to pharmacists, among others, for help with their day-to-day health concerns. Additionally, a growing proportion of elderly consumers, with a higher incidence of injuries from accidents such as falls, is also driving demand for many products that can help deal with injuries at home. Overall, in 2011 retail sales of medicated skin care products grew by 2% in current value terms to reach C$349 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Consumer Healthcare held a 25% value share of medicated skin care sales in 2011. The number one allergy remedies/antihistamines brand – Benadryl – remained one of the company’s best-selling brands. Polysporin and Monistat also make up a significant proportion of McNeil’s portfolio. All are well established in Canadian mainstream retail. Also, Polysporin is supported by advertising and product development, including the new Poly To Go on-the-go format for Polysporin.

PROSPECTS

  • Retail sales of medicated skin care products are projected to see a constant value CAGR of 2% over the forecast period to reach C$386 million in 2016.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 74 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 75 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 76 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 77 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 78 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Canada - Category Analysis

HEADLINES

TRENDS

  • The retail sales of NRT smoking cessation aids increased by 2% to C$142 million in 2011. This increase was due in large part to the combined efforts of anti-smoking organisations and government initiatives to curb smoking in Canada. Provinces across Canada have bans on smoking in public areas such as office buildings, malls, restaurants and bars. These restrictions have greatly boosted anti-smoking initiatives by creating yet another barrier for smokers.

SWITCHES

COMPETITIVE LANDSCAPE

  • McNeil Consumer Healthcare effectively controls the NRT smoking cessation aids environment in Canada, with an 86% value share in 2011. The company’s leading brands, Nicorette and Nicoderm, held value shares of 84% and 88% of NRT gum and NRT patches respectively at the end of the review period. Nicorette programmes such as ActiveStop, run by McNeil, offer support and help for smokers looking to give up. First-mover advantage and the resultant high level of consumer brand awareness, as well as the fact that these brands remain by far the most recommended by Canadian pharmacists and most visible in advertising (which once again reinforces consumers’ top-of-mind awareness) make it hard for other players to increase their value shares.

PROSPECTS

  • Retail sales of NRT smoking cessation aids are projected to see a constant value CAGR of 1% over the forecast period to reach C$148 million in 2016. Growth will come as a result of on-going battles to reduce the level of smoking in Canada. New legislative initiatives will continue to discourage smoking and are also expected to support demand for products that help to curb cravings “on the go”. These include the new British Columbia anti-smoking initiative, which helps meet the cost of NRT aids by reimbursing consumers for selected OTC and Rx products, as well as further smoking bans, such as the early 2012 ban on ban smoking in bar and restaurant patios, city-run beaches and parks, and at any festival run on city property in Ottawa.

CATEGORY INDICATORS

  • Table 79 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 80 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 81 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 82 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 83 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 84 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 85 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Canada - Category Analysis

HEADLINES

TRENDS

  • A survey by Health Canada in 2010 found that 18% of Canadians aged 18 and over were considered obese. This survey was self-reported, but it points to a growing trend among Canadian consumers regarding obesity. With the number of health risk factors associated with being overweight it is unsurprising that an increasing number of Canadians are looking to improve their overall health by losing weight and gaining muscle mass. Additionally, industry sources indicate that many older men are turning towards sport nutrition products for their general daily nutrient intake.

COMPETITIVE LANDSCAPE

  • Weider Nutrition Group (Canada) Ltd remained number one at the end of the review period with a 17% value share. Weider is able to maintain a high level of sales through strong retailer distribution. This network of retailers includes Wal-Mart, Loblaws, Shoppers Drug Mart and Real Canadian Superstore, among others.

PROSPECTS

  • Over the forecast period it is expected that sports nutrition products such as protein powders and bars will see a greater presence in mainstream retail to increase appeal to those Canadians seeking to increase their level of physical activity, and baby boomers in particular seeking to maintain more active lifestyles and improve their physical appearance.

CATEGORY DATA

  • Table 87 Sales of Sports Nutrition: Value 2006-2011
  • Table 88 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 89 Sports Nutrition Company Shares 2007-2011
  • Table 90 Sports Nutrition Brand Shares 2008-2011
  • Table 91 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 92 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Canada - Category Analysis

HEADLINES

TRENDS

  • The country’s ageing population along with increased emphasis on preventative healthcare continued to be among the key drivers of demand for vitamins and dietary supplements in Canada in 2011. Between 2006 and 2011, the number of Canadians over the age of 65 increased from 13% of the population to over 14% of the total population. Additionally, consumer surveys released in Canada indicate that the use of natural health products is higher among older Canadians, with many being among early adopters of products such as multivitamins, Omega and glucosamine. As the ageing trend continues, marketers of vitamins and dietary supplements have been adapting to this change by focussing product development and marketing on the needs of older consumers.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Jamieson Laboratories Ltd accounted for the largest proportion of sales in 2011, accounting for a 22% value share in vitamins and dietary supplements. The company’s flagship brand – Jamieson Natural Sources – has a presence across vitamins and dietary supplements and is available in the vast majority of major retailers across the country. The brand has been available for a long time and among the first to work with Health Canada to obtain drug identification number for its products, long before the introduction of new natural health product regulations. This helped the product build customer trust as well as ease its way into the new operating environment once the new regulations came into effect in 2004. A BrandSpark study released in 2011 indicated that Jamieson Natural Sources is among the top trusted health brands in the country, after Tylenol.

PROSPECTS

  • The number of senior Canadians over the age of 65 is projected to grow by 37% to approach seven million by 2020. Increasing demand from senior Canadians combined with growing awareness of the preventative health benefits of many vitamins and dietary supplements will continue to support demand over the forecast period.

CATEGORY DATA

  • Summary 12 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 93 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 94 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 95 Dietary Supplements by Positioning 2006-2011
  • Table 96 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 97 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 98 Vitamins Brand Shares by Value 2008-2011
  • Table 99 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 100 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Canada - Category Analysis

HEADLINES

TRENDS

  • Canadians continue to struggle with weight-related issues. Although a recent survey indicates some turning point in appreciation for the need to incorporate healthier diets and more exercise into daily routines, overall population studies point to a high level of overweight and obese Canadians – between 15% and 25% of the population (depending on the methodology of studies).

COMPETITIVE LANDSCAPE

  • Unilever Canada Inc represents the lion’s share of sales in weight management with a 59% value share and sales worth C$108 million in 2011. In meal replacement slimming products Unilever’s Slim Fast Optima dominates, holding a 73% value share at the end of the review period. With a marketing plan focused on providing consumers with an easy-to-follow weight loss strategy, Slim Fast Optima has become the meal replacement slimming leader. This weight loss strategy is built around Slim Fast products, and the basics of the daily meal plan involve three snacks, two Slim Fast shakes or meal bars, and one balanced meal.

PROSPECTS

  • Statistics from the Organisation for Economic Co-operation and Development (OECD) project an increase to the number of Canadians who are obese by 5% over the next 10 years. With Canadians’ hectic lifestyles, they will continue to seek convenient and effective ways to lose weight, which will continue to positively affect sales of weight management products over the forecast period.

CATEGORY DATA

  • Table 102 Sales of Weight Management: Value 2006-2011
  • Table 103 Sales of Weight Management: % Value Growth 2006-2011
  • Table 104 Weight Management Company Shares 2007-2011
  • Table 105 Weight Management Brand Shares 2008-2011
  • Table 106 Forecast Sales of Weight Management: Value 2011-2016
  • Table 107 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Canada - Category Analysis

HEADLINES

TRENDS

  • Canadian society has reached a tipping point. With reports showing that 26% of Canada’s youth are either overweight or obese (with estimates for the overall Canadian population ranging from 15% to 25%, depending on study methodology) Canadians are beginning to take notice and make changes to their lifestyle. National organisations such as ParticipACTION are gaining traction among Canadians, and helping to increase the level of physical activity. This new, higher, level of physical activity is among factors driving growth in wound care.

COMPETITIVE LANDSCAPE

  • Johnson & Johnson (Canada) Inc continued to account for the largest value share in wound care at the end of the review period at 41% in 2011. Johnson & Johnson’s top-selling brand, Band-Aid, accounted for a 42% value share in sticking plasters/adhesive bandages in Canadian retail. Band-Aid is effectively a household name when it comes to sticking plasters, well known and well-established, with a wide range of products. It is continuously supported by media advertising campaigns to retain a high level of brand awareness. The brand, however, is facing competitive pressure from other branded products as well as private label products. Additionally, Johnson & Johnson is also the number one selling brand of first aid kits and gauze, tape and other wound care products with value shares of 45% and 37% respectively in 2011.

PROSPECTS

  • As Canadians increasingly move towards more active lifestyles and as the population continues to age, demand for home wound care products will continue to see steady growth. Over the forecast period, retail sales of wound care products are projected to see a constant value CAGR of 2% to reach C$118 million in 2016.

CATEGORY DATA

  • Table 108 Sales of Wound Care by Category: Value 2006-2011
  • Table 109 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 110 Wound Care Company Shares by Value 2007-2011
  • Table 111 Wound Care Brand Shares by Value 2008-2011
  • Table 112 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 113 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Devil's Claw
            • Flaxseed/Linseed
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!